Advances in machine learning for tumour classification in cancer of unknown primary: A mini-review

IF 10.1 1区 医学 Q1 ONCOLOGY Cancer letters Pub Date : 2025-02-28 Epub Date: 2024-11-28 DOI:10.1016/j.canlet.2024.217348
Karen Oróstica , Felipe Mardones , Yanara A. Bernal , Samuel Molina , Marcos Orchard , Ricardo A. Verdugo , Daniel Carvajal-Hausdorf , Katherine Marcelain , Seba Contreras , Ricardo Armisen
{"title":"Advances in machine learning for tumour classification in cancer of unknown primary: A mini-review","authors":"Karen Oróstica ,&nbsp;Felipe Mardones ,&nbsp;Yanara A. Bernal ,&nbsp;Samuel Molina ,&nbsp;Marcos Orchard ,&nbsp;Ricardo A. Verdugo ,&nbsp;Daniel Carvajal-Hausdorf ,&nbsp;Katherine Marcelain ,&nbsp;Seba Contreras ,&nbsp;Ricardo Armisen","doi":"10.1016/j.canlet.2024.217348","DOIUrl":null,"url":null,"abstract":"<div><div>Cancers of unknown primary (CUP) are a heterogeneous group of aggressive metastatic cancers where standardised diagnostic techniques fail to identify the organ where it originated, resulting in a poor prognosis and resistance to treatment. Recent advances in large-scale sequencing techniques have enabled the identification of mutational signatures specific to particular tumour subtypes, even from liquid biopsy samples such as blood. This breakthrough paves the way for the development of new cost-effective diagnostic strategies. This mini-review explores recent advancements in Machine Learning (ML) and its application to tumour classification methods for CUP patients, identifying its weaknesses and strengths when classifying the tumour type. In the era of multi-omics, integrating several sources of information (e.g., imaging, molecular biomarkers, and family history) requires important theoretical advancements: increasing the dimensionality of the problem can result in lowering the predictive accuracy and robustness when data is scarce. Here, we review and discuss different architectures and strategies for incorporating cutting-edge machine learning into CUP diagnosis, aiming to bridge the gap between theory and clinical practice.</div></div>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":"611 ","pages":"Article 217348"},"PeriodicalIF":10.1000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304383524007432","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Cancers of unknown primary (CUP) are a heterogeneous group of aggressive metastatic cancers where standardised diagnostic techniques fail to identify the organ where it originated, resulting in a poor prognosis and resistance to treatment. Recent advances in large-scale sequencing techniques have enabled the identification of mutational signatures specific to particular tumour subtypes, even from liquid biopsy samples such as blood. This breakthrough paves the way for the development of new cost-effective diagnostic strategies. This mini-review explores recent advancements in Machine Learning (ML) and its application to tumour classification methods for CUP patients, identifying its weaknesses and strengths when classifying the tumour type. In the era of multi-omics, integrating several sources of information (e.g., imaging, molecular biomarkers, and family history) requires important theoretical advancements: increasing the dimensionality of the problem can result in lowering the predictive accuracy and robustness when data is scarce. Here, we review and discuss different architectures and strategies for incorporating cutting-edge machine learning into CUP diagnosis, aiming to bridge the gap between theory and clinical practice.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
机器学习在未知原发肿瘤分类中的研究进展
未知原发癌(CUP)是一种异质性的侵袭性转移性癌症,标准化诊断技术无法确定其起源器官,导致预后不良和对治疗的抵抗。大规模测序技术的最新进展已经能够识别特定肿瘤亚型的突变特征,甚至可以从液体活检样本(如血液)中识别。这一突破为开发新的具有成本效益的诊断策略铺平了道路。这篇迷你综述探讨了机器学习(ML)的最新进展及其在CUP患者肿瘤分类方法中的应用,在分类肿瘤类型时确定其弱点和优势。在多组学时代,整合多个信息来源(如成像、分子生物标志物和家族史)需要重要的理论进步:当数据稀缺时,增加问题的维度可能会导致预测准确性和鲁棒性降低。在这里,我们回顾并讨论了将尖端机器学习纳入CUP诊断的不同架构和策略,旨在弥合理论与临床实践之间的差距。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer letters
Cancer letters 医学-肿瘤学
CiteScore
17.70
自引率
2.10%
发文量
427
审稿时长
15 days
期刊介绍: Cancer Letters is a reputable international journal that serves as a platform for significant and original contributions in cancer research. The journal welcomes both full-length articles and Mini Reviews in the wide-ranging field of basic and translational oncology. Furthermore, it frequently presents Special Issues that shed light on current and topical areas in cancer research. Cancer Letters is highly interested in various fundamental aspects that can cater to a diverse readership. These areas include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal actively focuses on experimental therapeutics, particularly the advancement of targeted therapies for personalized cancer medicine, such as metronomic chemotherapy. By publishing groundbreaking research and promoting advancements in cancer treatments, Cancer Letters aims to actively contribute to the fight against cancer and the improvement of patient outcomes.
期刊最新文献
YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastoma Blocking CEMIP2-mediated low-molecular-weight hyaluronic acid -TGFβ signaling inhibits chemotherapy-associated lymphatic metastasis in gastric cancer SLC28A1 inhibits clear cell renal cell carcinoma progression by affecting arachidonic acid metabolism: A novel nucleoside transporter-based targeted therapy strategy Uncontrolled hyperglycemia-induced membrane cholesterol dysregulation drives tumor immune evasion by reducing hardness of tumor cell plasma membrane The Yin and Yang of tertiary lymphoid structures in primary liver cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1